穩健醫療(300888.SZ):目前感染防護類產品動銷處於非常態的低速水平
格隆匯6月20日丨有投資者向穩健醫療(300888.SZ)提問:感染防護產品預計全年業務體量能達到什麼水平?
穩健醫療回覆:一季度醫療業務整體實現營業收入13.6億元,其中感染防護產品實現營業收入6.2億元。由於環境變化後短期的購買慣性,一二月份以口罩為代表的感染防護產品仍處於年內銷售高位,進入三月份以後銷售趨勢開始顯著走低。目前感染防護類產品動銷處於非常態的低速水平,不僅是由於需求產生明顯變化,更是由於需求端庫存處於高位水平,需要一定時間消化去庫存。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.